EPISODE · Dec 24, 2019 · 33 MIN
Targeted Therapies In Renal Cell Carcinoma
from AUAUniversity · host American Urological Association
Co-Host: Jay Raman, MD, FACS At the conclusion of these activities, participants will be able to: 1. Review the mechanisms of action, efficacy, and safety of currently available targeted treatment of RCC. 2. Facilitate discussions with patients and caregivers regarding RCC treatment options. CME Available: auau.auanet.org/node/26091 This educational series is supported by independent educational grants from: Amgen Astellas AstraZeneca Bristol-Myers Squibb Genomic Health Merck Pfizer, Inc. Sanofi Genzyme UroGen Pharma
What this episode covers
Co-Host: Jay Raman, MD, FACS At the conclusion of these activities, participants will be able to: 1. Review the mechanisms of action, efficacy, and safety of currently available targeted treatment of RCC. 2. Facilitate discussions with patients and caregivers regarding RCC treatment options. CME Available: auau.auanet.org/node/26091 This educational series is supported by independent educational grants from: Amgen Astellas AstraZeneca Bristol-Myers Squibb Genomic Health Merck Pfizer, Inc. Sanofi Genzyme UroGen Pharma
NOW PLAYING
Targeted Therapies In Renal Cell Carcinoma
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.